The Transcription Factor NF-κB in Stem Cells and Development

NF-κB (nuclear factor kappa B) belongs to a family of transcription factors known to regulate a broad range of processes such as immune cell function, proliferation and cancer, neuroprotection, and long-term memory. Upcoming fields of NF-κB research include its role in stem cells and developmental processes. In the present review, we discuss one role of NF-κB in development in Drosophila, Xenopus, mice, and humans in accordance with the concept of evo-devo (evolutionary developmental biology). REL domain-containing proteins of the NF-κB family are evolutionarily conserved among these species. In addition, we summarize cellular phenotypes such as defective B- and T-cell compartments related to genetic NF-κB defects detected among different species. While NF-κB proteins are present in nearly all differentiated cell types, mouse and human embryonic stem cells do not contain NF-κB proteins, potentially due to miRNA-dependent inhibition. However, the mesodermal and neuroectodermal differentiation of mouse and human embryonic stem cells is hampered upon the repression of NF-κB. We further discuss NF-κB as a crucial regulator of differentiation in adult stem cells such as neural crest-derived and mesenchymal stem cells. In particular, c-REL seems to be important for neuronal differentiation and the neuroprotection of human adult stem cells, while RELA plays a crucial role in osteogenic and mesodermal differentiation.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

Cells - 10(2021), 8 vom: 10. Aug.

Sprache:

Englisch

Beteiligte Personen:

Kaltschmidt, Christian [VerfasserIn]
Greiner, Johannes F W [VerfasserIn]
Kaltschmidt, Barbara [VerfasserIn]

Links:

Volltext

Themen:

Adult stem cells
Development
Differentiation
Embryonic stem cells
Journal Article
MicroRNAs
NF-κB
NF-kappa B
REL
Research Support, Non-U.S. Gov't
Review
Transcription Factor RelA

Anmerkungen:

Date Completed 19.11.2021

Date Revised 03.04.2024

published: Electronic

Citation Status MEDLINE

doi:

10.3390/cells10082042

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM329837192